IgA Nephropathy after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34278290/
ANCA glomerulonephritis after Moderna: https://www.kidney-international.org/article/S0085-2538(21)00555-X/fulltext
Nephrotic Syndrome following AstraZeneca: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257404/
ANCA associated Glomerulonephritis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34423176/
ANCA associated vasculitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34416184/
IgA and crescentic glomerulonephritis following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141343/
Nephrotic syndrome and vasculitis following Pfizer, Moderna, and AstraZeneca: https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfab215/6318785
De novo vasculitis after Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166777/
3 cases of minimal change disease following 2nd dose of mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34337193/
Minimal Change disease and Severe AKI following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34242687/
Minimal Change Disease Following Pfizer: https://pubmed.ncbi.nlm.nih.gov/33839200/
Minimal Change Disease relapse following Pfizer: https://www.ajkd.org/article/S0272-6386(21)00627-2/fulltext
MCD relapse following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137360/
MCD relapse following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098029/
Severe MCD relapse 3 days following Pfizer: https://europepmc.org/article/pmc/pmc8156905
Minimal change disease and AKI following Pfizer: https://www.kidney-international.org/article/S0085-2538(21)00493-2/pdf
Minimal Change disease following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149162/
IgA nephropathy in 2 pediatric patients after Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256683/
IgA and crescentic glomerulonephritis following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141343/
3 cases of IgA nephropathy patients developing exacerbations following mRNA vaccine: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166778/
2 cases of IgA nephropathy patients developing exacerbations following moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987498/
IgA nephropathy flare up following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079938/
IgA Nephropathy after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34278290/
ITP following Astrazeneca: https://ashpublications.org/blood/article/doi/10.1182/blood.2021012790/476455/Immune-Thrombocytopenic-Purpura-after-vaccination
IgA nephropathy in 2 pediatric patients after Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256683/
2 cases of IgA Nephropathy patients developing hematuria after Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329426/
IgA nephropathy flare-up following vaccination: https://pubmed.ncbi.nlm.nih.gov/34415336/
Membranous nephropathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34419553/
Membranous nephropathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34332960/
ANCA-Associated Vasculitis Following Pfizer-BioNTech: https://www.ajkd.org/article/S0272-6386(21)00742-3/fulltext?fbclid=IwAR1NWbOTsNpAQK6qF-FvAdnlc1gMsYHzklO7PKB8AlHkV-iLnhGScTFpPfo
New onset ANCA vasculitis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34280507/